Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.91

+1.5%

Nov 18 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tomato who wrote (649)	1/19/2005 3:17:13 PM
From: Jibacoa	Read Replies (1) of 3722

INCY is still on a near term downtrend coming from its Dec.3 H at 10.91 The presentation at JPMorgan HealthCare conference last week wasn't of much help. You may recall that in December Piper Jaffray listed INCY among its stock picks for 2005 and said that its Reverset "could be the next breakthrough drug for HIV.".<g> INCY has had 4 consecutive Qs of revenues decreasing on a sequential basis and significant % compared with previous year.(Dec., Mar.,Jun. and Sep. Qs revenues were: 10.3M, 6.6M, 5.2M and 3.4M respectively and compared to prior year were: -51%, -47%, -53% and -74% <g> To get off its present downtrend INCY needs to close above its Jan,3 H of $10.11 in order to test its Dec.3 H at $10.91 and then its Oct.4 H at 11.16 bigcharts.marketwatch.com Once it can close above $11.16 the outlook improves.<g> The long term chart remains interesting and the insiders reportedly did some buying in the last half of 2004(most of it in August, at the start of the run from the $5 to the $11 level deal <g>) bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next